NCT05793034 Predictive Factors for Survival in Aggressive Meningiomas
| NCT ID | NCT05793034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Meningioma |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2021-01-07 |
| Primary Completion | 2026-01-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2021-01-07 with a primary completion date of 2026-01-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.
Eligibility Criteria
Inclusion Criteria: 1. Patient operated for atypical (grade 2) meningioma; or 2. Patient operated for anaplastic (grade 3) meningioma; 3. Timeframe for surgery, 1999-2019 Exclusion criteria 1\) Patient lost at follow-up
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05793034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Meningioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05793034 currently recruiting?
Yes, NCT05793034 is actively recruiting participants. Contact the research team at alessandro.olivi@policlinicogemelli.it for enrollment information.
Where is the NCT05793034 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT05793034 clinical trial?
NCT05793034 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 250 participants.